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1. Introduction
  Degenerative Disc Disease (DDD) is a common health 
problem in invertebrates, including humans[1]. It is a chronic 
disease that involves multiple-factors that progressively 
destroys the composition, structure and function of the 
disc[2,3]. The main pathological features that characterize 
DDD include collagen type conversion, progressive loss 
of extracellular matrix proteoglycans, disc dehydration, 
increased expression and activity of matrix-degrading 
enzymes and inflammatory factors accumulation[1,4,5]. 
Immune cell accumulation and increased inflammatory 
cytokine expressions have been identified in degenerative 
disc tissues[6-10], indicating that inflammatory cytokines 
may play an important role in the disc degeneration 
process[11,12].
  Interleukin-17 (IL-17), a powerful inflammatory 
cytokine, plays critical roles in the pathogenesis of 
various inflammatory disorders[13]. Studies on arthritis 
found that IL-17 can, by itself or combined with other 
inflammatory cytokines, induce inflammatory cytokine 
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aggregation, inhibit aggrecan synthesis, and up-regulate 
the aggrecan enzyme and degrading collagen molecules; 
thus, contributing to joint degeneration[14,15]. Chondrocyte-
like cells, similar to articular chondrocytes, is the main cell 
type found in the nucleus pulposus (NP) of the human disc, 
suggesting that IL-17 may be involved in disc degeneration 
similar to joint degeneration. Scuderi et al revealed that the 
epidural space lavage in patients with lumbar intervertebral 
disk herniation and radiculopathy contained an increased 
expression of IL-17[16], suggesting that IL-17 may be 
involved in intervertebral disc tissue degeneration which 
may also be associated with the development of pain. With 
further analysis, Shamji et al[17] identified that nucleus 
pulposus cells cultured in vitro not only responded with a 
catabolic phenotype to IL-17 stimulation, but also expressed 
surface ligands with a consequential potential to recruit 
additional lymphocytes and immune cells into the DDD 
microenvironment. Perhaps IL-17 may be an important 
inflammation regulator in DDD pathologies. So far, studies 
have shown that IL-17 may be involved in the process of 
disc degeneration; however, the contribution of inflammatory 
IL-17 cytokines in disc degeneration through inhibiting 
cell proliferation, the extracellular matrix synthesis 
of intervertebral disc cells, as well as promoting the 
degradation of aggrecan enzyme expressions and collagen 
molecules, still needs to be investigated.
  Based on this background, we found the importance 
of examining the response of isolated nucleus pulposus 
cells from IL-17 stimulated degenerative disc tissues; and 
hypothesized that IL-17 can inhibit the proliferation and 
destruction of extracellular matrix tissue homeostasis in 
nucleus pulposus cells cultured in vitro.
2. Materials and methods
2.1. Clinical cases 
  Out of the 36 patients that visited our hospital for lumbar 
disc herniation surgery, between December 2013 and March 
2014, 20 patients (12 males, 8 females) were enrolled as 
subjects for this study, after obtaining informed consents. 
The patients had average age of (68.4依7.7) years old. The 
extent of disc degeneration of each subject was from levels 
栿 to 桇, which was graded using Thompson’s classification 
by magnetic resonance imaging[18]. The subjects had no prior 
history of surgery, serious infection, cancer, hypotension, 
and diabetes, which was confirmed by questionnaire and 
pathological examination after operation.
2.2. Cell separation and culturing 
  During surgery, NP tissues was dissected, stripped from the 
annulus and cartilage tissues, and immersed in saline for 
subsequent analysis, within 30 minutes. Using scissors, the 
collected human NP tissues were cut into small pieces. The 
NP cells were enzymatically released from the NP tissues by 
digestion, using a combined solution of 0.25% trypsin and 
0.025% collagenase for half an hour at 37 曟. After 10 minutes 
of centrifugation at 1 000 rpm, the supernatant was removed. 
Subsequently, cell clumps were resuspended with Ham’s 
F12 media (Gibco), combined with 10% fetal bovine serum, 
100 毺g/mL of penicillin and 100 毺g/mL of streptomycin 
(culture medium), for cell counting; and it was inoculated 
on a gelatin-coated tissue culture plastic with 5% CO2 at
37 曟. All cells were seeded at an approximate density of 
25 000 cells per cm2, the medium was changed every other 
day. Cell morphology and density were observed under an 
inverted microscope DIAVERT. Cell passage was established 
when approximately 80% cell fusion was achieved[19]. Cells 
after three passages were used in all experiments.
2.3. IL-17 stimulation 
  For cell proliferation analysis: NP cells were plated 
at a density of 50 000 cells per well in 48-well plates 
(n=6 replicates) with an overlaid culture medium of 
150 毺L. In order to determine the optimal IL-17 dosage for 
all experiments, the inhibition effects of IL-17 on NP cells 
were first evaluated over a broad range of doses (0-20 ng/
mL). After 72 hours, the cultured cells were collected and 
the proliferation rate were measured by MTS analysis.
  For cell metabolism analysis: NP cells were plated at 
a density of 50 000 cells per well in 48-well plates (n=6 
replicates), overlaid with 300 毺L of the following culture 
mediums: fresh culture medium without IL-17 (unstimulated 
group), fresh culture medium with concentrations identified 
during theIL-17 cell proliferation analysis (stimulated 
group). After culturing for 48 and 96 hours, the mRNA 
expression and protein levels were measured by real-time 
PCR and Western blot analysis.
2.4. Cell proliferation and metabolism measurement
2.4.1. Cell proliferation measurement
  Cell proliferation was determined by MTS assay; the 
CellTiter 96® AQueous One Solution Cell Proliferation Assay 
kit was used, based on manufacturer’s instructions. Briefly, 
3 hours before each of the desired time points, 20 毺L of 
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MTS reagent was added into each well, and the cells were 
incubated at 37 曟 for 3 hours. Then, a 550 BioRad plate-
reader (Bio-Rad, Hertfordshire, UK) was used, and an optical 
density (OD) value of OD490 was detected. All experiments 
were repeated three times[20]. Cell suppression ratio was 
calculated, according to the following formula: (stimulated 
group OD - unstimulated group OD)/(unstimulated group OD 
- background OD).
2.4.2. Reagents and instruments
  DMEM/F12 Medium (Gibco, USA); fetal bovine serum 
(Gibco, USA):0.25% trypsin (Invitrogen, USA); Collagenase
栻 (Invitrogen , USA):DMSO(Invitrogen, USA); Penicillin and 
Streptomycin(Invitrogen, USA); SuperScript® 栿 First Strand 
kits (Takara, China): CellTiter 96® AQueous One Solution 
Cell Proliferation Assay kit (Promega, USA).
  Ce l l  incuba to r  ( Heraeus ,  Germany ) ;  Inver ted 
microscope (Olympus, Japan); Clean bench (Shenggong 
Tecnology Company, Shanghai): Digital thermostat 
water bath (Shenggong Tecnology Company, Shanghai): 
Spectrophotometer.
2.4.3. Total RNA extraction and RT-PCR analysis
  Total RNA was isolated from the two groups of cells using 
TRIzol Reagent (Gibco) and the cells were immediately 
reverse-transcribed using oligo (dT); then, cDNA was 
generated from 5 毺g of total RNA  in 20 毺L reaction mixes 
using SuperScript® 栿 First Strand kits (Takara), and stored 
at -20 曟 for later use. All procedures were conducted 
according to manufacturer’s instructions. Primers for the 
following genes were designed by using Oligo 6.0 (National 
Biosciences Inc., Plymouth, MN) and synthesized by Sangon 
Biotech (Shanghai, China): glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), aggrecan (ACAN), collagen, type 
栺, alpha 1 (COL1A1), collagen, type 栻, alpha 1 (COL2A1), 
matrix metalloprotease-3 (MMP-3), stromolysin, matrix 
metalloprotease-1 (MMP-1), collagenase, a disintegrin 
and metalloproteinase with thrombospondin motifs 4 
(ADAMTS4), a disintegrin and metalloproteinase with 
thrombospondin motifs 5 (ADAMTS5), tissue inhibitor of 
matrix metalloprotease-1 (TIMP-1), tissue inhibitor of matrix 
metalloprotease-13 (TIMP-13). The detailed sequences of the 
primer pairs are shown in Table 1. 
  The mRNA expression levels were quantified by real-time 
PCR using the Mas tercycler®ep Rea lplex Thermal Cycler 
(Eppendorf, Hamburg, Germany) and Thunderbird SYBR® 
qPCR Mix (Toyobo, Osaka, Japan) to detect PCR products. 
The 25 毺L PCR reaction mixture contained 5 毺L of cDNA, 
12.5 毺L of Thunderbird SYBR® qPCR Mix, 0.2 mM of dNTP, 
and 0.5 毺M of each primer (Toyobo). The reaction mixture 
was denatured at 95 曟 for 2 minutes, followed by 40 cycles 
of PCR reactions in the following settings: 95 曟, 15 seconds; 
60 曟, 15 seconds; and 72 曟, 45 seconds. The expression 
level of each target gene was normalized to GAPDH 
expression. Normalized mRNA expression (in ΔCt units) 
was calculated by subtracting the cycle threshold (Ct) of the 
target gene from the Ct value of the house-keeping genes: 
ΔCt (target gene)=Ct (target gene) - Ct (GAPDH).
Table 1 
Gene sequences and primer information.
Gene GenBank Accession NO. Primer pair (5’- 3’) Length of product (bp)
ACAN NM_001135 For: CAGAATCAACTGCTGCAGACCA 227
Rev: TTCGATGGTCCTGTCGTTCAG
COL1A1 NM_000088 For: AGTGGTTTGGATGGTGCCAA 170
Rev: GCACCATCATTTCCACGAGC
COL2A1 NM_001844 For: GGGACTGtTCCTCTGCGACGACA 172
Rev: CTTTGGTCCTGGTTGCCCACT
MMP3 NM002422 For: TGAGGACACCAGCATGAACC 248
Rev: ACTTCGGGATGCCAGGAAAG
MMP13 NM002427 For: CATGAGTTCGGCCACTCCTT 230
Rev: CCTCGGAGACTGGTAATGGC
ADAMTS4 NM005099 For: CACATTCTTGTCCGGCAGCA 489
Rev: CCCCTCCCCACTGAGTCTTA
ADAMTS5 NM007038 For: ACTTTCCTTTGGCACACCCA 230
Rev: ACGTCACTGACCACTGTTGG
TIMP1 NM003254 For: GCGGATACTTCCACAGGTCC 242
Rev: CTGGTCCGTCCACAAGCAAT
TIMP3 NM000362 For: CCCTCCCACAAGTGGACATC 139
Rev: ACTCCGCAGGGAAACTTCAG
GAPDH NM002046 For: TCAAGATCATCAGCAATGCC 227
Rev: TGTGGTCATGAGTCCTTCCA
Note: For, forward; Rev, reverse.
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2.4.4. Western blot analysis
  After the IL-17 stimulation of NP cells cultured in vitro, a 
Western blot analysis was conducted to measure the protein 
levels of ACAN, COL1A1, COL2A1, ADAMTS4, and ADAMTS5 
genes with polyclonal goat anti-ACAN antibody, polyclonal 
goat anti-COL1A1 antibody , polyclonal goat anti-COL2A1 
antibody, polyclonal goat anti-ADAMTS4 antibody, and 
polyclonal goat anti-ADAMTS4 antibody (sc-16492, sc-8784, 
sc-7764, sc-16534, Santa Cruz Biotechnology Company; LS-
C124924-100, LifeSpanBioSciences Inc.).
  Cells were harvested and washed twice with ice-cold PBS. 
Lysates were obtained with a TEN-T buffer (150 mM NaCl, 
10 mM Tris-HCl, pH 7.4, 5 mM EDTA, pH 8.0, 1% Triton 
X-100, 1 mM PMSF, 2 毺g/mL aprotinin) and was subjected 
to 10 000暳g centrifugation at 4 曟 for 20 minutes. The BCA 
Protein Assay Kit (Beyotime) was used to measure the protein 
concentration of the supernatants. Per lane, 50毺g of protein 
was electrophoresed in 12% SDS polyacrylamide gels and 
transferred onto nitrocellulose membranes (Sigma). After 
blocking with TTBS (50 mM Tris-HCl, pH 7.4, 0.5 M NaCl, 
0.05% Tween-20) containing 5% (w/v) skimmed milk, the 
membranes were incubated with first antibodies overnight at 
4 曟, followed by horseradish peroxidase-conjugated second 
antibody incubation (Santa Cruz Biotechnology Company). 
Immunoreactive bands were detected by Super ECL Plus 
Detection Reagent (Amersham).
2.5. Statistical analysis
  All tests were repeated three times. Statistical analysis 
was carried out using Student’s t-test with SPSS software. 
Results are presented as mean依SD. P<0.05 was considered 
statistically significant.
3. Results
3.1. IL-17 stimulation effects on cell proliferation
  In 72 hours, IL-17 stimulation induced a dose-dependent 
decrease in proliferation rate. With the IL-17 dosage range 
(0-20 ng/mL), the suppression ratios were 3.89%依0.65%, 
6.87%依1.05%, 8.35%依0.77%, 12.89%依0.64%, and 12.80%依
1.56%, respectively. The 15 ng/mL concentration showed 
significantly stronger inhibition effect on nucleus pulposus 
cell proliferation than 2 ng/mL (t=17.089, P=0.000), 5 ng/
mL (t=8.479, P=0.001), and 10 ng/mL (t=7.854, P=0.001); 
however, the difference was not significant compared with 
20 ng/mL (t=0.015, P=0.99). These results suggest that IL-
17 stimulation induced the proliferation rate to decrease in 
cultured NP cells, and the inhibition effect on 15 ng/mL of 
IL-17 was significantly stronger. A 15 ng/mL concentration 
of IL-17 was used to stimulate nucleus pulposus cells 
cultured in vitro for metabolic analysis.
3.2. IL-17 stimulation effects on cell metabolism
3.2.1. IL-17 stimulation effects on gene mRNA expression 
  After 48 and 96 hours of treatment with 15 ng/mL IL-
17, a significant decrease on ACAN expression levels were 
observed; MMP3 expression levels were significantly 
elevated; a significant decrease of COL1A1 mRNA was noted 
after 48 hours (P<0.05), and the significance disappeared 
after 96 hours; a significant increase of TIMP3 mRNA was 
noted after 48 hours (P<0.05), and the significance also 
disappeared after 96 hours. The expression levels of COL2A1, 
MMP13, ADAMTS4, ADAMTS5 and TIMP1 also responded to 
IL-17 stimulation, but no significant changes were noted 
(Table 2).
3.2.2. IL-17 stimulation effects on protein expression
  The effects of IL-17 (15 ng/mL) on the protein levels 
of ACAN, COL1A1, COL2A1, ADAMTS4 and ADAMTS5 
were measured by Western blot analysis (Figure 3). NP 
cells demonstrated a greater decrease in COL1A1 protein 
expression after 48 hours (t=3.199, P=0.006) and a significant 
increase in ADAMTS5 protein expression (t=2.667, P=0.021), 
compared with the unstimulated group. However, both 
Table 2 
Normalized mRNA expressions (ΔCt unit) in annulus fibrosus cells exposed to interleukin-17 for (A) 48 hrs and (B) 96 hrs compared with 
unstimulated cells.
Time Gene ACAN COL1A1 COL2A1 MMP3 MMP13 ADAMTS4 ADAMTS5 TIMP1 TIMP3
48 h S   7.22依2.08 11.90依3.85   8.82依3.02  5.44依2.27 7.43依3.16 11.19依4.11 13.44依3.67 10.33依2.33   8.22依3.29 
US   4.55依2.66   8.20依1.43   7.44依2.69 8.89依3.88 8.22依2.77 13.22依3.88 11.55依4.22 11.47依3.05 12.02依4.00
t 2.372 2.703 1.024 2.302 0.564 1.077 1.014 0.891 2.201
P   0.031*   0.022* 0.321   0.035* 0.581 0.297 0.326 0.386   0.043*
96 h S 10.44依3.34   8.22依2.99 10.22依3.55   7.03依2.89 11.40依4.25 10.22依4.22 5.44依2.34 8.39依2.77 11.22依4.00
US   7.00依2.27   9.33依3.22   8.99依3.96 10.55依2.91   9.22依3.55 12.25依3.59 6.37依3.12 6.88依2.49 10.42依2.98
t 2.555 0.758 0.694 2.575 1.181 1.099 0.715 1.216 0.481
P   0.021* 0.460 0.498   0.020* 0.255 0.288 0.485 0.242 0.637
Note: * P<0.05, compared with unstimulated cells. S: stimulated; US: unstimulated.
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significant changes disappeared after 96 hours (t=0.359, 
P=0.724; t=0.538, P=0.568). At this time point, COL2A1 
protein levels greatly increased, compared with the 
unstimulated group (t=4.411, P=0.000).
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Figure 3. Protein expression in annulus fibrosus cells exposed 
to interleukin-17 for (A) 48 hrs and (B) 96 hrs compared with 
unstimulated cells.
* P<0.05, compared with unstimulated cells; ** P<0.01, compared 
with unstimulated cells.
4. Discussion
  IL-17 is a cytokine factor that has recently shown to be 
elevated in degenerated human intervertebral disc tissues[6], 
suggesting that an in-depth investigation of its involvement 
in disc degeneration may help us better understand the 
DDD process. In this study, through establishing cultured 
nucleus pulposus cells in vitro, the inhibiting effects of 
different IL-17 concentrations on nucleus pulposus cell 
proliferation was analyzed. After IL-17 exposure, nucleus 
pulposus cell metabolic changes were explored in order to 
identify the possible role of IL-17 in the pathogenesis of disc 
degeneration from an extracellular matrix balance aspect.
  Within 72 hours, IL-17 stimulation in cultured NP cells 
induced a dose-dependent proliferation inhibition rate. 
The suppression ratio increased as the concentrations 
were increased, and the suppression ratio of IL-17 at a 
concentration of 15 ng/mL had the highest results. Based on 
the analysis of Gabr et al, they found that NP cells increased 
its nitric oxide (NO) production over the 72 hour culture 
period in the presence of IL-17, with a maximal effect noted 
for IL-17 doses higher than 10 ng/mL[17]. This result was 
basically consistent with the results of our experiments. 
The suppression ratio of IL-17 at 20 ng/mL concentration 
also showed no significant difference, perhaps due to the 
complete saturation of the IL-17 receptors in NP cells[21]. 
Until now, the mechanism of the proliferation inhibiting 
effects of IL-17 on NP cells is still unknown. However, it 
is known that NO, another inflammatory factor, is involved 
in DDD development, through promoting apoptosis[22], and 
IL-17 can significantly induce the expression of nitric 
oxide synthase, thereby, contributing to NO molecule 
generation[23]. IL-17 may also play a role in inhibiting cell 
proliferation by indirectly inducing apoptosis in the NP 
cells.
  A IL-17 at 15 ng/mL concentration was used to stimulate 
the NP cells cultured in vitro for metabolic analysis. We 
found that ACAN and COL1A1 mRNA levels were significantly 
down regulated by IL-17 after 48-h culture. After 96 
hours, the ACAN mRNA levels in stimulated group were 
still significantly down regulated. Western blot results 
showed that COL1A1 protein levels in stimulated group were 
significantly higher than the unstimulated group. Collagen 
type 栻 mRNA expression was down regulated at two time 
points, but no significant differences were noted, compared 
with unstimulated group. Based on the experiments of Seguin 
et al, NP cells formed in vitro were treated with TNF-毩, a 
proinflammatory cytokine, over 48 hours[24], and the tissues 
were assessed for proteoglycan and collagen synthesis. They 
found that TNF-毩 induced the decreased expressions of 
both aggrecan and type 栻 collagen genes, suggesting that 
decreasing the synthesis of matrix macromolecules may 
be one of the main functions of inflammatory cytokines 
in disc degeneration. Besides the decrease in matrix 
macromolecules synthesis[25,26], a gradual transition from 
type 栺 collagen to type 栻 collagen was observed[27]. In 
our analysis, the down regulation of type 栺 collagen was 
not observed after IL-17 stimulation, but the COL2A1 gene 
protein level was significantly lower, compared with the 
unstimulated group (time point: 96 hours). One possible 
explanation is that within 48 hours, NP cells responded to 
IL-17 stimulation with a decreased type 栺 collagen protein 
synthesis; and also, the collagen type transition enabled the 
observation of increased type 栺 collagen protein level and 
decreased type 栻 protein level. The results suggest that IL-
17 may be involved in tissue matrix homeostasis destruction 
through inhibiting matrix macromolecules synthesis and 
collagen type transition.
  Nucleus pulposus cells not only synthesize extracellular 
matrix macromolecules, but also synthesize a variety of 
enzymes for matrix degradation[28,29]. A variety of enzyme 
changes in IL-17 stimulated NP cells were noted in our 
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analysis. Compared with the unstimulated group, the mRNA 
levels of the MMP3 gene significantly increased after 48 
and 96 hours of stimulation; and the significant increase in 
TIMP3 mRNA levels were noted at the 48-hour time point; 
an additional evidence that DDD develops, as specific gene/
protein expression increases, such as the MMP3 and TIMP3 
genes identified by Liang et al[30,31], which indicated that IL-
17 may directly or indirectly contribute to disc degeneration 
through other mechanisms. ADAMTS4, ADAMTS5, and TIMP1 
mRNA levels also increased after IL-17 stimulation, but 
compared with the unstimulated group, no significant 
differences were noted. A possible reason, for the absence 
of significant response to IL-17 stimulation, is that the 
expression of these genes has already been up-regulated 
in vivo since the time the NP cells were isolated from 
degenerative human discs. After 48 hours of stimulation, 
ADAM-TS5 gene protein levels were significantly up-
regulated, probably due to the response of ADAMTS5 mRNA 
translation from IL-17 stimulation. All these results have 
shown that IL-17 stimulation increased the synthesis and 
activity of degrading enzymes in NP cells, which therefore 
enhanced disc extracellular matrix degradation and further 
promoted the degradation process.
  IL-17 stimulation effects on the proliferation and 
metabolism of nucleus pulposus cells cultured in vitro 
were analyzed. Our findings suggest that IL-17 can inhibit 
proliferation and possibly contribute to the degenerative 
changes that occur in disc disease, through inhibiting 
extracellular matrix synthesis, promoting nucleus pulposus 
extracellular matrix degradation and disrupting metabolic 
balance.
  Despite the effectiveness of using a model where nucleus 
pulposus cells were cultured in vitro to study the process of 
disc degeneration, previous studies have also demonstrated 
gene expression changes in culturing intervertebral disc 
cells[32-35]. In order to minimize any potential phenotypic 
changes, we used third passage cells for all experiments. 
Clearly, the in vitro results presented in this study cannot 
be directly used to interpret the function of IL-17 in vivo; 
however, we hope that the identified responses of IL-17 
stimulation would be further considered for DDD. Future 
studies are needed to identify the specific changes of normal 
and degenerative cells that respond to IL-17 only or in 
combining IL-17 with other inflammatory cytokinesboth 
in vitro and in vivo; and how these results may be further 
exploited to facilitate its beneficial effects on tissue matrix 
homeostasis.
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